Management ChangeAug 5, 2026, 04:19 PM
GoodRx Appoints Justin Fengler as New CFO; Christopher McGinnis Departs
AI Summary
GoodRx Holdings, Inc. announced that Christopher McGinnis will transition from his role as Chief Financial Officer & Treasurer, effective August 5, 2026. His departure is not due to any disagreements with the company. The Board of Directors appointed Justin Fengler, the current Chief Strategy & Operations Officer, to also serve as CFO & Treasurer, effective August 6, 2026. Mr. Fengler will receive equity awards totaling $1.2 million and a $100,000 cash payment in connection with his appointment.
Key Highlights
- Christopher McGinnis will transition from his role as CFO & Treasurer, effective August 5, 2026.
- Justin Fengler, current Chief Strategy & Operations Officer, appointed CFO & Treasurer, effective August 6, 2026.
- Mr. Fengler will continue to oversee the Company’s strategy and operations.
- Mr. Fengler will receive a restricted stock unit award valued at $600,000.
- Mr. Fengler will receive a performance stock unit award valued at $600,000.
- Mr. Fengler will receive a one-time cash payment of $100,000.
- Mr. McGinnis's departure is not due to any disagreement with the Company.
- Mr. McGinnis will receive severance payments and benefits as a Tier I participant.
Price Impact
More from GDRX